These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 6319859

  • 1. Physical separation of the agonist and antagonist forms of a mu opiate receptor?
    Jauzac P, Puget A, Meunier JC.
    Life Sci; 1983; 33 Suppl 1():195-8. PubMed ID: 6319859
    [Abstract] [Full Text] [Related]

  • 2. Differential regulation of two molecular forms of a mu-opioid receptor type by sodium ions, manganese ions and by guanyl-5'-yl imidodiphosphate.
    Jauzac P, Frances B, Puget A, Moisand C, Meunier JC.
    J Recept Res; 1986; 6(1):1-25. PubMed ID: 3012080
    [Abstract] [Full Text] [Related]

  • 3. Apparent precoupling of kappa- but not mu-opioid receptors with a G protein in the absence of agonist.
    Frances B, Puget A, Moisand C, Meunier JC.
    Eur J Pharmacol; 1990 Jul 31; 189(1):1-9. PubMed ID: 2171960
    [Abstract] [Full Text] [Related]

  • 4. Distinct molecular forms of opiate binding in the frog brain.
    Puget A, Jauzac P, Meunier JC.
    Life Sci; 1983 Jul 31; 33 Suppl 1():199-202. PubMed ID: 6319860
    [Abstract] [Full Text] [Related]

  • 5. 5'-Guanylylimidodiphosphate decreases affinity for agonists and apparent molecular size of a frog brain opioid receptor in digitonin solution.
    Mollereau C, Pascaud A, Baillat G, Mazarguil H, Puget A, Meunier JC.
    J Biol Chem; 1988 Dec 05; 263(34):18003-8. PubMed ID: 2848020
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Opiate receptor(s) of the frog brain: soluble-phase separation of the macromolecular complexes of an agonist and an antagonist].
    Puget A, Meunier JC.
    C R Seances Acad Sci III; 1983 Dec 05; 296(10):475-8. PubMed ID: 6307492
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The kappa-opioid receptor from human placenta: hydrodynamic characteristics and evidence for its association with a G protein.
    Porthé G, Francés B, Verrier B, Cros J, Meunier JC.
    Life Sci; 1988 Dec 05; 43(6):559-67. PubMed ID: 2841553
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Guanine nucleotides inhibit binding of agonists and antagonists to soluble opiate receptors.
    Koski G, Simonds WF, Klee WA.
    J Biol Chem; 1981 Feb 25; 256(4):1536-8. PubMed ID: 6257676
    [Abstract] [Full Text] [Related]

  • 16. In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method.
    Richards ML, Sadée W.
    Eur J Pharmacol; 1985 Aug 27; 114(3):343-53. PubMed ID: 2998812
    [Abstract] [Full Text] [Related]

  • 17. [3H]-etorphine and [3H]-diprenorphine receptor binding in vitro and in vivo: differential effect of Na+ and guanylyl imidodiphosphate.
    Kurowski M, Rosenbaum JS, Perry DC, Sadée W.
    Brain Res; 1982 Oct 14; 249(2):345-52. PubMed ID: 6291717
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.